Insider Transactions in Q1 2022 at Aziyo Biologics, Inc. (AZYO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2022
|
Thomas Englese CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
276
-4.01%
|
-
|
|
Mar 08
2022
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,288
+13.66%
|
-
|
|
Mar 08
2022
|
Jerome Riebman CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
782
+12.79%
|
-
|
|
Mar 08
2022
|
Ronald K. Lloyd PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,072
+11.36%
|
-
|
|
Mar 08
2022
|
Darryl Roberts EVP, OPERATIONS & PRODUCT DEV. |
BUY
Exercise of conversion of derivative security
|
Direct |
938
+21.98%
|
-
|
|
Mar 08
2022
|
Thomas Englese CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
938
+11.99%
|
-
|